About Us

Publications

BMT CTN investigators have published >135 manuscripts, including >30 primary study results papers, in numerous peer-reviewed journals, including the New England Journal of Medicine, Journal of Clinical Oncology, and Blood. Selected publications are summarized for dissemination to patients and the lay public.

Note: Some Publications were unable to be listed below - please see that listing here. All other publications based on PubMedIDs are listed below.

 

Found 6 results
Filters: Keyword is Remission Induction  [Clear All Filters]
2019
E. A. Stadtmauer, Pasquini, M. C., Blackwell, B., Hari, P., Bashey, A., Devine, S., Efebera, Y., Ganguly, S., Gasparetto, C., Geller, N., Horowitz, M. M., Koreth, J., Knust, K., Landau, H., Brunstein, C., McCarthy, P., Nelson, C., Qazilbash, M. H., Shah, N., Vesole, D. H., Vij, R., Vogl, D. T., Giralt, S., Somlo, G., and Krishnan, A., “Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial.”, J Clin Oncol, vol. 37, no. 7, pp. 589-597, 2019.
2016
G. G. Laport, Wu, J., Logan, B., Bachanova, V., Hosing, C., Fenske, T., Longo, W., Devine, S. M., Nademanee, A., Gersten, I., Horowitz, M., Lazarus, H. M., and Riches, M. L., “Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and High-Dose Rituximab for Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma: A Phase Two Multicenter Trial from the Blood and Marrow Transplant Clinical Trials Networ”, Biol Blood Marrow Transplant, vol. 22, no. 8, pp. 1440-1448, 2016.
2015
N. Khera, Majhail, N. S., Brazauskas, R., Wang, Z., He, N., Aljurf, M. D., Akpek, G., Atsuta, Y., Beattie, S., Bredeson, C. N., Burns, L. J., Dalal, J. D., Freytes, C. O., Gupta, V., Inamoto, Y., Lazarus, H. M., LeMaistre, C. F., Steinberg, A., Szwajcer, D., Wingard, J. R., Wirk, B., Wood, W. A., Joffe, S., Hahn, T. E., Loberiza, F. R., Anasetti, C., Horowitz, M. M., and Lee, S. J., “Comparison of Characteristics and Outcomes of Trial Participants and Nonparticipants: Example of Blood and Marrow Transplant Clinical Trials Network 0201 Trial.”, Biol Blood Marrow Transplant, vol. 21, no. 10, pp. 1815-22, 2015.
S. M. Devine, Owzar, K., Blum, W., Mulkey, F., Stone, R. M., Hsu, J. W., Champlin, R. E., Bin Chen, Y. -, Vij, R., Slack, J., Soiffer, R. J., Larson, R. A., Shea, T. C., Hars, V., Sibley, A. B., Giralt, S., Carter, S., Horowitz, M. M., Linker, C., and Alyea, E. P., “Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncolo”, J Clin Oncol, vol. 33, no. 35, pp. 4167-75, 2015.
2011
M. R. Tomblyn, Ewell, M., Bredeson, C., Kahl, B. S., Goodman, S. A., Horowitz, M. M., Vose, J. M., Negrin, R. S., and Laport, G. G., “Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response.”, Biol Blood Marrow Transplant, vol. 17, no. 7, pp. 1051-7, 2011.
2010
P. A. Jacobson, Huang, J., Wu, J., Kim, M., Logan, B., Alousi, A., Grimley, M., Bolaños-Meade, J., Ho, V., Levine, J. E., and Weisdorf, D., “Mycophenolate pharmacokinetics and association with response to acute graft-versus-host disease treatment from the Blood and Marrow Transplant Clinical Trials Network.”, Biol Blood Marrow Transplant, vol. 16, no. 3, pp. 421-9, 2010.